Records 1 - 19
| Association of ERCC gene polymorphism with osteosarcoma risk.
African health sciences 2020 Dec 20 (4): 1840-1848.
Wang Guanliang, Li Jianping, Xu Xiling, Gupta Ramit Kumar, Gao Xiaoqia
| Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population.
Medicine 2018 Dec 97 (49): e13358.
Liu Dabiao, Liu Xueso
| ERCC polymorphisms and risk of osteosarcoma: a meta-analysis.
European review for medical and pharmacological sciences 2018 Oct 22 (20): 6658-6666.
Chen X-J, Tong Z-C, Kang X, Wang Z-C, Huang G-L, Yang T-M, Dong
| The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
BMC medical genetics 2018 Jul 19 (1): 112.
Obiedat Hadeel, Alrabadi Nasr, Sultan Eyad, Al Shatti Marwa, Zihlif Mal
| Association between common polymorphisms in ERCC gene and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis.
OncoTargets and therapy 2018 11 3495-3504.
Li Chunpu, Yu Xin, Guo Dongmei, Liu Guanhua, Zhang Kaigang, Teng Qingliang, Lin H
| Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis.
Oncotarget 2017 Sep 8 (37): 62769-62779.
Liu Xueyong, Zhang Zhan, Deng Chunbo, Tian Yihao, Ma X
| Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
World journal of surgical oncology 2017 Apr 15 (1): 75.
Zhang Haiguang, Ge Junbo, Hong Huanyu, Bi Lili, Sun Zhengw
| Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer.
Oncology letters 2015 Apr 9 (4): 1657-1661.
Gómez-Díaz Benjamín, DE LA Luz Ayala-Madrigal María, Gutiérrez-Angulo Melva, Valle-Solis Aura Erazo, Linares-González Luis Miguel, González-Guzmán Roberto, Cruz-Guillén David, Cedeño-Garcidueñas Ana Lilia, Canto Patricia, López-Hernández Luz Bereni
| Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma.
Cancer epidemiology 2015 Apr 39 (2): 182-8.
Gori?ar Katja, Kova? Viljem, Jazbec Janez, Zakotnik Branko, Lamovec Janez, Dolžan Vi
| Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma.
Genetics and molecular research : GMR 2015 14 (3): 10145-51.
Cao Z H, Yin H P, Jiang N, Yu
| Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
International journal of clinical and experimental pathology 2015 8 (7): 7905-12.
Sun Yongjian, Wu Yi, Li Weicheng, Kong Zhen, Zou Xiaomi
| Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
Genetics and molecular research : GMR 2015 14 (3): 11652-7.
Wang M J, Zhu Y, Guo X J, Tian Z
| Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma.
Genetics and molecular research : GMR 2015 14 (3): 11235-41.
Zhang Q, Lv L Y, Li B J, Zhang J, Wei
| Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
International journal of clinical and experimental pathology 2015 8 (1): 894-9.
Ji Wei-Ping, He Neng-B
| ERCC polymorphisms and prognosis of patients with osteosarcoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Oct 35 (10): 10129-36.
Li Jinsong, Liu Shaohua, Wang Weiguo, Zhang Kexiang, Liu Zhendong, Zhang Chaoyue, Chen Shijie, Wu So
| Association of four ERCC1 and ERCC2 SNPs with survival of bone tumour patients.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (8): 3821-4.
Hao Ting, Feng Wei, Zhang Jie, Sun Yong-Jian, Wang Ga
| Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (11): 5883-6.
Yang Li-Min, Li Xiu-Hua, Bao Cui-F
| Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
The pharmacogenomics journal 2009 Oct 9 (5): 347-53.
Caronia D, Patiño-García A, Milne R L, Zalacain-Díez M, Pita G, Alonso M R, Moreno L T, Sierrasesumaga-Ariznabarreta L, Benítez J, González-Neira
| Single nucleotide polymorphisms of nucleotide excision repair and homologous recombination repair pathways and their role in the risk of osteosarcoma.
Pakistan journal of medical sciences 0 31 (2): 269-73.
Jin Guojun, Wang Min, Chen Weida, Shi Wei, Yin Jiapeng, Gang Wa